Research Institute of Molecular Pathology (IMP)
Created in 1985
- BETA
Up & running (A)
Existing signals show a regular activity Social networks
27,144 15,547Activities
Technologies
Entity types
Location
Campus-Vienna-Biocenter 1, 1030 Wien, Austria
Wien
Austria
Employees
Scale: 201-500
Estimated: 195
Engaged corporates
2
1 2Added in Motherbase
5 years, 7 months ago
deeptech Value proposition
A leading basic research institute addressing fundamental questions in molecular biology. Part of Vienna BioCenter.
The Research Institute of Molecular Pathology (IMP) in Vienna is a basic biomedical research institute largely sponsored by Boehringer Ingelheim. With over 200 scientists from 40 countries, the IMP is committed to scientific discovery of fundamental molecular and cellular mechanisms underlying complex biological phenomena. Research areas include cell and molecular biology, microscopy, immunology and cancer, developmental biology, chromosome biology, and computational biology.
Molecular Biology, Disease Mechanisms, Computational biology, Immunology, Cell Biology, Chromosome Biology, Gene Regulation, Developmental Biology, and Microscopy
Research Institute of Molecular Pathology (IMP) | Molecular Biology at Vienna BioCenter
The Research Institute of Molecular Pathology (IMP) is a leading molecular biology institute in Europe, situated at Vienna BioCenter.
https://www.imp.ac.at/
| Corporate | Type | Tweets | Articles | |
|---|---|---|---|---|
 Boehringer Ingelheim Pharmaceutical, Pharmaceutical Manufacturing, Animal Health | Boehringer Ingelheim Pharmaceutical, Pharmaceutical Manufacturing, Animal Health | Other 26 Apr 2023 18 May 2023 | | |
 Institut Curie Health, Hospitals and Health Care | Institut Curie Health, Hospitals and Health Care | Other 17 Jul 2018 | | |